Medtronic plc, MDT is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Medtronic plc, MDT has a market cap of 114287.02. Since its IPO date on the 12/31/1981, Medtronic plc, MDT performance year to date is 8.61%. Today Medtronic plc, MDT has gained -0.72%, with a current price of 82.71.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 85.70%. The management of the company have seen the company have a payout ratio of 60.40%. Return of assets are at 3.60%, with return on investment at 5.40%.
In terms of debt levels and profit levels, Medtronic plc, MDT is seeing a long-term debt/equity of 0.59. While Total debt/equity is 0.63. With a profit margin of 12.70%, this is combined with a gross margin of 68.90%, and operating margin of 18.50%. Medtronic plc ability to meet debt levels, with a current ratio of 3, while the quick ratio is 2.5.
For the last year Medtronic plc, MDT has seen a EPS growth of 2.90%. A performance for the year of 13.77%. The 52-week high is -7.35%, and the 52-week low is 17.62%. The average volume for Medtronic plc, MDT is 4042211.
With a target price of 94.68, can Medtronic plc, MDT reach this target? Looking at the value indicators of Medtronic plc, MDT. Medtronic plc has a P/E of 32.15 and a forward P/E of 15.96. Perhaps the more useful indicator than P/E, is PEG which has a value of 4.03. Medtronic plc also has a P/S and a P/B of 3.98 and 2.27 respectively. For P/cash, Medtronic plc has a value of 8.92, while it is 43.96 for P/free cash flow.
At the current price of 82.71, Medtronic plc has a dividend yield of 2.08%. We see a return on equity of 7.10%.
Looking more long-term Medtronic plc, is projected to get an EPS growth for the next five years of 7.98%. In the short-term an EPS growth of 11.25% in the next year is forecasted. This is after a EPS growth of 2.90% for this year and for the last five years a -2.60% growth has been seen.